title: Ibrutinib--a new standard treatment for relapsed mantle cell lymphoma?
authors.affiliation: Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: pem9019@med.cornell.edu.
authors.forename: Peter
authors.initials: P
authors.lastname: Martin
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy*; D008297:Male; D010880:Piperidines; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; C401859:temsirolimus; D000225:Adenine; D020123:Sirolimus